Article
Del(20q) in patients with chronic lymphocytic leukemia: a therapy-related abnormality involving lymphoid or myeloid cells.
Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc - 1 Aug 2015
Yin C Cameron, Tang Guilin, Lu Gary, Feng Xiaoli, Keating Michael J, Medeiros L Jeffrey, Abruzzo Lynne V
Abstract excerpt
Deletion 20q (Del(20q)), a common cytogenetic abnormality in myeloid neoplasms, is rare in chronic lymphocytic leukemia. We report 64 patients with chronic lymphocytic leukemia and del(20q), as the sole abnormality in 40, a stemline abnormality in 21, and a secondary abnormality in 3 cases. Fluorescence in situ hybridization (FISH) analysis revealed an additional high-risk abnormality, del(11q) or del(17p), in...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
